Acadia Healthcare (ACHC) 8-K Acadia Healthcare Third Quarter Adjusted EPS Increases to $0.30 from $0.17 as Adjusted Income from Continuing Operations More Than Doubles

Exhibit 99

Acadia Healthcare Third Quarter Adjusted EPS Increases to $0.30 from $0.17 as Adjusted Income from Continuing Operations More Than Doubles

Same Facility Revenue Expands 9.9%

Raises 2013 Earnings Guidance to $1.06 to $1.07

FRANKLIN, Tenn.--(BUSINESS WIRE)--October 29, 2013--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2013. Revenue increased 79.1% to $184.7 million for the third quarter from $103.1 million for the third quarter of 2012. Income from continuing operations was $14.5 million, or $0.29 per diluted share, for the third quarter of 2013 compared with $6.6 million, or $0.16 per diluted share, for the third quarter of 2012. Adjusted income from continuing operations increased 115.3% to $15.2 million for the third quarter of 2013 from $7.1 million for the third quarter of 2012 and increased 76.5% to $0.30 per diluted share from $0.17 per diluted share, reflecting a 19.9% increase in weighted average shares outstanding for the comparable quarters, primarily due to Acadia’s public equity offering in December 2012. The adjusted results exclude transaction-related expenses of $1.0 million and $0.7 million for the third quarter of 2013 and 2012, respectively. A reconciliation of all GAAP and non-GAAP financial results in this release is on pages 7 and 8.

For the first nine months of 2013, revenue was $523.4 million, up 78.5% from $293.2 million for the first nine months of 2012. Income from continuing operations was $30.9 million, or $0.61 per diluted share, for the first nine months of 2013 compared with $16.0 million, or $0.43 per diluted share, for the same period in 2012. Adjusted income from continuing operations increased 125.7% to $39.1 million for the first nine months of 2013 from $17.3 million for the first nine months of 2012 and increased 66.0% to $0.78 per diluted share from $0.47 per diluted share, reflecting a 35.7% increase in weighted average shares outstanding for the comparable periods, primarily due to Acadia’s public equity offerings in May 2012 and December 2012. The adjusted results for the first nine months of 2013 exclude debt extinguishment costs of $9.4 million and transaction-related expenses of $3.8 million and, for the first nine months of 2012, exclude transaction-related expenses of $2.1 million.

Joey Jacobs, Chairman and Chief Executive Officer of Acadia, commented, “We continue to be pleased with the execution of our proven business model, which produced very strong profitable growth for the third quarter of 2013. Our revenue growth primarily resulted from the acquisition and integration of 15 inpatient psychiatric facilities since the end of the third quarter last year, including the acquisition of an 87-bed facility that was consummated in the third quarter of 2013. These acquisitions, combined with both the addition of 263 beds to existing facilities and the opening of a 60-bed de novo facility in the past 12 months, increased our licensed beds to approximately 3,900 at the quarter’s end from more than 2,400 at the end of the third quarter last year.

“The increase in third-quarter revenue also reflected 9.9% growth in same-facility revenue, driven by new beds added to the same facility base and by our ongoing revenue-generating initiatives in each facility. Same facility patient days increased 8.4% for the third quarter and revenue per patient day rose 1.4%. Our same facility EBITDA margin was 25.3% for the latest quarter compared with 25.8% for the third quarter of 2012. The Company’s adjusted consolidated EBITDA increased 82.6% to $38.5 million, or 20.8% of revenue, for the third quarter of 2013 from $21.1 million, or 20.4% of revenue, for the third quarter of 2012.

“We continue to generate significant net cash from continuing operations, with growth of 32.4% to $17.1 million for the quarter. At September 30, 2013, we had approximately $81 million of availability under our revolving credit facility and a ratio of total net debt to trailing 12 months adjusted EBITDA, as calculated under our credit agreement, of 4.1.”

Based on Acadia’s performance for the first nine months of 2013 and its outlook for the remainder of the year, the Company today raised its guidance for 2013 adjusted earnings per diluted share to a new range of $1.06 to $1.07 from the previous range of $1.01 to $1.03. The Company’s guidance does not include transaction-related expenses, debt extinguishment costs and the impact of any future acquisitions.

Acadia will hold a conference call to discuss its second quarter financial results at 9:00 a.m. Eastern Time on Wednesday, October 30, 2013. A live webcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available through November 12, 2013.

Risk Factors

This news release contains forward-looking statements. Generally words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this news release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) Acadia’s ability to complete acquisitions and successfully integrate the operations of the acquired facilities; (ii) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from the government and third-party payors; (iv) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; and (v) potential operating difficulties, client preferences, changes in competition and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategy. These factors and others are more fully described in Acadia’s periodic reports and other filings with the SEC.

About Acadia

Acadia is a provider of inpatient behavioral healthcare services. Acadia operates a network of 50 behavioral healthcare facilities with approximately 4,100 licensed beds in 22 states and Puerto Rico. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.

Acadia Healthcare Company, Inc.
Consolidated Statements of Operations
(Unaudited)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
	(in thousands, except per share amounts)
Revenue before provision for doubtful accounts	$	190,574		$	104,618		$	539,230		$	298,638
Provision for doubtful accounts		(5,872	)		(1,502	)		(15,821	)		(5,429	)
Revenue		184,702			103,116			523,409			293,209
Salaries, wages and benefits (including equity-based compensation expense of $1,331, $521, $3,744 and $1,691, respectively)		103,789			59,888			298,904			173,590
Professional fees		8,956			4,690			27,294			13,521
Supplies		9,806			4,831			28,017			14,148
Rents and leases		2,656			1,775			7,377			6,244
Other operating expenses		22,345			11,380			59,424			30,768
Depreciation and amortization		4,414			2,076			12,248			5,332
Interest expense, net		9,465			7,433			27,672			22,186
Debt extinguishment costs		-			-			9,350			-
Transaction-related expenses		984			732			3,813			2,097
Total expenses		162,415			92,805			474,099			267,886
Income from continuing operations before income taxes		22,287			10,311			49,310			25,323
Provision for income taxes		7,741			3,723			18,439			9,307
Income from continuing operations		14,546			6,588			30,871			16,016
(Loss) income from discontinued operations, net of income taxes		(182	)		(138	)		(572	)		22
Net income	$	14,364		$	6,450		$	30,299		$	16,038
Basic earnings per share:
Income from continuing operations	$	0.29		$	0.16		$	0.62		$	0.44
Loss from discontinued operations		-			(0.01	)		(0.01	)		-
Net income	$	0.29		$	0.15		$	0.61		$	0.44
Diluted earnings per share:
Income from continuing operations	$	0.29		$	0.16		$	0.61		$	0.43
Loss from discontinued operations		-			(0.01	)		(0.01	)		-
Net income	$	0.29		$	0.15		$	0.60		$	0.43
Weighted-average shares outstanding:
Basic		50,040			41,757			49,987			36,795
Diluted		50,343			41,991			50,213			37,006

Acadia Healthcare Company, Inc.
Consolidated Balance Sheets
(Unaudited)
	September 30, 2013		December 31, 2012
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	4,034	$	49,399
Accounts receivable, net of allowance for doubtful accounts of $13,108 and $7,484, respectively		93,311		63,870
Deferred tax assets		13,019		11,380
Other current assets		32,516		16,332
Total current assets		142,880		140,981
Property and equipment, net		329,735		236,942
Goodwill		647,010		557,402
Intangible assets, net		19,183		15,988
Other assets		24,178		32,100
Total assets	$	1,162,986	$	983,413
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	13,305	$	7,680
Accounts payable		26,449		19,081
Accrued salaries and benefits		32,284		28,749
Other accrued liabilities		29,235		16,341
Total current liabilities		101,273		71,851
Long-term debt		571,955		465,638
Deferred tax liabilities - noncurrent		4,979		998
Other liabilities		18,246		12,376
Total liabilities		696,453		550,863
Equity:
Common stock		500		499
Additional paid-in capital		459,911		456,228
Retained earnings (accumulated deficit)		6,122		(24,177	)
Total equity		466,533		432,550
Total liabilities and equity	$	1,162,986	$	983,413

Acadia Healthcare Company, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
	Nine Months Ended September 30,
	2013			2012
	(In thousands)
Operating activities:
Net income	$	30,299		$	16,038
Adjustments to reconcile net income to net cash provided by continuing operating activities:
Depreciation and amortization		12,248			5,332
Amortization of debt issuance costs		1,686			1,869
Equity-based compensation expense		3,744			1,691
Deferred income tax expense		10,545			8,138
Loss (income) from discontinued operations, net of taxes		572			(22	)
Debt extinguishment costs		9,350			-
Other		16			(9	)
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		(18,378	)		(13,597	)
Other current assets		(5,657	)		(3,677	)
Other assets		(1,676	)		1,029
Accounts payable and other accrued liabilities		2,596			4,817
Accrued salaries and benefits		(3,467	)		527
Other liabilities		3,538			1,527
Net cash provided by continuing operating activities		45,416			23,663
Net cash used in discontinued operating activities		(541	)		(328	)
Net cash provided by operating activities		44,875			23,335
Investing activities:
Cash paid for acquisitions, net of cash acquired		(135,605	)		(165,981	)
Cash paid for capital expenditures		(50,678	)		(14,511	)
Cash paid for real estate acquisitions		(4,676	)		(50,745	)
Other		(1,088	)		1,231
Net cash used in investing activities		(192,047	)		(230,006	)
Financing activities:
Borrowings on long-term debt		150,000			25,000
Net increase in revolving credit facility		19,500			-
Principal payments on long-term debt		(5,625	)		(6,000	)
Repayment of long-term debt		(52,500	)		-
Payment of debt issuance costs		(4,307	)		(1,197	)
Payment of premium on note redemption		(6,759	)		-
Issuance of common stock		-			138,954
Proceeds from stock option exercises		233			515
Excess tax benefit from equity awards		1,265			-
Net cash provided by financing activities		101,807			157,272
Net decrease in cash and cash equivalents		(45,365	)		(49,399	)
Cash and cash equivalents at beginning of the period		49,399			61,118
Cash and cash equivalents at end of the period	$	4,034		$	11,719
Effect of acquisitions:
Assets acquired, excluding cash	$	163,706		$	172,267
Liabilities assumed		(16,417	)		(6,286	)
Prior year deposits paid for acquisitions		(11,684	)		-
Cash paid for acquisitions, net of cash acquired	$	135,605		$	165,981

Acadia Healthcare Company, Inc.
Operating Statistics
(Unaudited)
(Revenue in thousands)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2013			2012			% Change		2013			2012			% Change
Same Facility Results (a)
	Revenue	$	110,104		$	100,222		9.9	%	$	315,201		$	285,261		10.5	%
	Patient Days		183,330			169,142		8.4	%		522,684			478,137		9.3	%
	Admissions		8,040			7,680		4.7	%		23,278			21,722		7.2	%
	Average Length of Stay (b)		22.8			22.0		3.5	%		22.5			22.0		2.0	%
	Revenue per Patient Day	$	601		$	593		1.4	%	$	603		$	597		1.1	%
	EBITDA margin		25.3	%		25.8	%	-50 bps			26.2	%		24.2	%	200 bps
Total Facility Results
	Revenue	$	184,071		$	102,816		79.0	%	$	521,368		$	292,869		78.0	%
	Patient Days		276,193			176,478		56.5	%		788,383			499,615		57.8	%
	Admissions		14,804			7,737		91.3	%		41,870			21,908		91.1	%
	Average Length of Stay (b)		18.7			22.8		-18.2	%		18.8			22.8		-17.4	%
	Revenue per Patient Day	$	666		$	583		14.4	%	$	661		$	586		12.8	%
	EBITDA margin		24.5	%		25.5	%	-100 bps			24.2	%		23.9	%	30 bps
(a) Same facility results for the comparative three and nine months ended September 30, 2013 and 2012 have been adjusted for the impact of a conversion of 50 beds from residential to acute at one of the Company's facilities. The conversion began in the second quarter of 2013 and is expected to be completed in the first quarter of 2014.
(b) Average length of stay is defined as patient days divided by admissions.

Acadia Healthcare Company, Inc.
Reconciliation of Net Income to Adjusted EBITDA
(Unaudited)
	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
	(in thousands)				(in thousands)
Net income	$	14,364	$	6,450	$	30,299	$	16,038
Loss (income) from discontinued operations		182		138		572		(22	)
Provision for income taxes		7,741		3,723		18,439		9,307
Interest expense, net		9,465		7,433		27,672		22,186
Depreciation and amortization		4,414		2,076		12,248		5,332
EBITDA		36,166		19,820		89,230		52,841
Adjustments:
Equity-based compensation expense (a)		1,331		521		3,744		1,691
Debt extinguishment costs (b)		-		-		9,350		-
Transaction-related expenses (c)		984		732		3,813		2,097
Adjusted EBITDA	$	38,481	$	21,073	$	106,137	$	56,629
See footnotes on page 9.

Acadia Healthcare Company, Inc.
Reconciliation of Adjusted Income from Continuing Operations to Income from
Continuing Operations
(Unaudited)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
	(in thousands, except per share amounts)						(in thousands, except per share amounts)
Income from continuing operations	$	14,546		$	6,588		$	30,871		$	16,016
Provision for income taxes		7,741			3,723			18,439			9,307
Income from continuing operations before income taxes		22,287			10,311			49,310			25,323
Adjustments to income from continuing operations:
Debt extinguishment costs (b)		-			-			9,350			-
Transaction-related expenses (c)		984			732			3,813			2,097
Income tax provision/benefit reflecting tax effect of adjustments to income from continuing operations (d)		(8,082	)		(3,987	)		(23,359	)		(10,091	)
Adjusted income from continuing operations	$	15,189		$	7,056		$	39,114		$	17,329
Weighted-average shares outstanding - diluted		50,343			41,991			50,213			37,006
Adjusted income from continuing operations per diluted share	$	0.30		$	0.17		$	0.78		$	0.47
See footnotes on page 9.

Footnotes

We have included certain financial measures in this press release, including EBITDA, Adjusted EBITDA and Adjusted income from continuing operations, which are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the SEC. We define EBITDA as net income adjusted for loss (income) from discontinued operations, net interest expense, income tax provision and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for equity-based compensation expense, transaction-related expenses, and debt extinguishment costs.

EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are not measures of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as measures of our liquidity. Our measurements of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA, Adjusted EBITDA and Adjusted income from continuing operations in this press release because we believe that such information is used by certain investors as measures of a company’s historical performance. We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present EBITDA, Adjusted EBITDA and Adjusted income from continuing operations when reporting their results. Our presentation of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

(a) Represents the equity-based compensation expense of Acadia.

(b) Represents debt extinguishment costs related to the repayment of $52.5 million of the Company's 12.875% Senior Notes due 2018 on March 12, 2013, including a prepayment premium of $6.8 million and the write-off of $2.6 million of deferred financing costs.

(c) Represents transaction-related expenses incurred by Acadia related to acquisitions.

(d) Represents the income tax provision adjusted to reflect the aggregate tax effect of the adjustments to income from continuing operations described above based on effective tax rates.

CONTACT:
Acadia Healthcare Company, Inc.
Brent Turner, 615-861-6000
President